A doctor's positive attitude to Alzheimer's diagnosis and their personal relationships with support services are powerful enablers for early diagnosis. However, barriers include differing health priorities, fear of damaging the doctor-patient relationship, and difficulties in referring patients to support services. GPs need education o...
A team of researchers led by Dr. Nicholas Lang is studying three ancient Martian volcanoes to better understand the planet's history and potential water sources. The study may have implications for the search for life on Mars, as liquid water could have existed in the past.
Researchers at Mount Sinai School of Medicine have found that a natural compound called NIC5-15 may be a safe and effective treatment for mild to moderate Alzheimer's disease. The preliminary findings suggest that NIC5-15 can prevent the formation of beta-amyloid plaque, a key factor in cognitive decline.
A new study suggests that partnering with local physicians, conducting educational seminars, and utilizing community outreach are effective tools in recruiting people for Alzheimer's clinical studies. In contrast, patient registries and internet recruiting were found to be less successful strategies. The study also explores the importa...
A new study found that delaying ACL reconstruction in young athletes under 14 can lead to a four-fold increase in irreparable medial meniscus tears. The study highlights the need for continued injury prevention efforts, suggesting that the risks of delaying treatment may outweigh the benefits.
A study found that clozapine, restricted due to safety concerns, is associated with lower mortality compared to other antipsychotics. Long-term use of any antipsychotic reduces mortality by around 20%, indicating restrictions may have caused thousands of extra deaths worldwide.
Two large studies using DHA showed mixed results, with no benefit in people with mild to moderate Alzheimer's but a positive result in healthy older adults. The findings highlight the need for earlier detection and diagnosis of Alzheimer's disease, as well as further research on genetic interactions.
GUMC researchers discover that a gamma secretase inhibitor can reduce neuronal loss and protect against motor and cognitive deficits in animal models of traumatic brain injury. This finding supports the connection between Alzheimer's disease and traumatic brain injury, suggesting novel therapeutic targets.